Sectors

Inovio Pharmaceuticals spinoff Geneos Therapeutics will put the proceeds from the series A1 round towards advancing its liver cancer vaccine candidate.

Exploiting UChicago research, Reflexion is eyeing an expansion in Asia after receiving $40m in additional series D funding to bring the round to $150m.

Q&A with Nicolas Autret, investment director, Samsung Catalyst Fund

Arise Industrial Services paid $12m for a 35% share of the carbon emissions certificate provider, valuing it at $34.5m.

Salesforce Ventures, NTT Docomo Ventures, DTCP and Telstra Ventures are set to exit the authentication technology developer in an all-stock transaction.

SoftBank and existing Doma investor Lennar are contributing to a $300m PIPE deal that will support the property transaction technology provider's reverse merger.

Echo Health Ventures and Humana have returned to back the healthcare delivery provider’s series D round, which valued it at $1.7bn.

GLP has returned to participate in a series D round for the e-commerce delivery platform developer to bring its total financing above $240m.

The Pfizer and Johnson & Johnson-backed cancer treatment developer is eyeing expansion in Asia after receiving $40m in additional series D funding.

An unnamed care provider has added $20m to the $80m the software-based therapeutics developer received from investors including Novartis and SoftBank in December.

SoftBank Vision Fund had provided $1.45bn of funding for the supply chain financier, which is reportedly preparing for insolvency.